Company Overview

At the crossroads between Dosimetry, Medical Imaging and Digital technologies, DOSIsoft develops cutting-edge software solutions for Radiation Oncology and Nuclear Medicine. Founded in 2002, DOSIsoft is a spin-off from the world famous Cancer Institutes Gustave Roussy and Institut Curie in Paris, France. 15 years of innovation and R&D investments have led to world leading software solutions used successfully in over 160 hospital centers in 18 countries around the world.

DOSIsoft’s software solutions provide exclusive and distinctive features to assist physicians and physicists in the diagnosis, planning, quality assurance and treatment follow-up of cancer, either by External Beam Radiation Therapies or Targeted Radionuclide Therapies. DOSIsoft’s multimodality imaging solutions are also applicable for the diagnosis or neurodegenerative diseases.

DOSIsoft is expanding internationally thanks to a direct sales and by working with a growing number of specialized local distributors. DOSIsoft opened in 2016 a new DOSIsoft branch in Miami, USA, to address the specific requirements of the North and South American markets.

Our mission is to improve the quality of treatment in Radiation Oncology and Nuclear Medicine. We provide highly sophisticated and efficient software solutions to reduce risks and enhance therapy outcome.

"Our ambition is to increase the cancer survival rate by improving the quality and efficiency of cancer radiation therapies."

Hanna Kafrouni, PhD, President and Founder of DOSIsoft

Our Commitment

Constantly Innovating

We constantly develop innovative software solutions, in collaboration with major cancer treatment and research centers. Our experts specialize in imaging analysis, scientifc modelling and digital technologies. We strive to improve the quality of treatment.

Providing Quality Solutions

Precise and accurate software solutions are the key tools for efficient Radiation Oncology. Our software solutions meet the ISO 9001 and ISO 13485 standards as well as the local requirements, such as CE marking and FDA clearance.

Addressing the Global Demand

Originally designed for the European market, major cancer centers from around the world quickly grew an interest towards our successful solutions. Today, we have our software solutions installed in Europe, Africa, Asia, Oceania and the Americas.

Reaching out to many patients

Today, our software solutions are used by more than 160 hospitals, in 18 countries, improving treatment for over 2 million patients. Our goal is to increase the number of cancer survivors in every part of the world.